BeOne Medicines
ONC
#648
Rank
โ‚น3.780 T
Marketcap
โ‚น33,415
Share price
-1.57%
Change (1 day)
14.12%
Change (1 year)
BeOne Medicines formerly known as BeiGene, is a multinational pharmaceutical company engaged in the R&D, commercialization of molecularly-targeted, and immuno-oncology drugs for the treatment of cancer.

EPS for BeOne Medicines (ONC)

EPS in 2026 (TTM): โ‚น434.74

According to BeOne Medicines's latest financial reports the company's current EPS (TTM) is โ‚น461.50. In 2025 the company made an earnings per share (EPS) of โ‚น261.93 an increase over its 2024 EPS that were of -โ‚น598.70.

EPS history for BeOne Medicines from 2015 to 2026

Annual EPS

Year EPS Change
2026 (TTM)โ‚น434.7465.98%
2025โ‚น261.93-143.75%
2024-โ‚น598.70
2022-โ‚น1,87128.21%
2021-โ‚น1,459-19.96%
2020-โ‚น1,82320.81%
2019-โ‚น1,50931.52%
2018-โ‚น1,148417.57%
2017-โ‚น221.71-37.16%
2016-โ‚น352.84158.95%
2015-โ‚น136.26

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
OPKO Health
OPK
-โ‚น25.91-105.61%๐Ÿ‡บ๐Ÿ‡ธ USA
Onconova Therapeutics
ONTX
-โ‚น91.15-119.75%๐Ÿ‡บ๐Ÿ‡ธ USA